Biodexa Pharmaceuticals (BDRX) Net Margin (2015 - 2021)
Biodexa Pharmaceuticals (BDRX) posted Net Margin of 276425.0% for Q4 2020, down 20.85% sequentially from 228725.0% in Q3 2020, and down 27245196.0% YoY from N/an in Q1 2020.
Biodexa Pharmaceuticals (BDRX) Net Margin (2015 - 2021) Analysis & Trends
Biodexa Pharmaceuticals has reported Net Margin for 4 years, with the latest figure at 276425.0% in Q4 2020.
- Quarterly Net Margin fell 27245196.0% year-over-year to 276425.0% in Q4 2020, while the trailing twelve-month figure through Dec 2020 was 4999.93% (changed N/A YoY) and the FY2023 annual result came in at 2069.82%, down 163248.0% from the prior year.
- Net Margin slipped to 276425.0% in Q4 2020 per BDRX's latest filing, from 228725.0% in the prior quarter.
- Over five years, Net Margin peaked at 1595.48% in Q4 2016 and troughed at 276425.0% in Q4 2020.
- A 3-year average of 127679.63% and a median of 116349.02% in 2019 frame the typical range for Net Margin.
- The sharpest annual moves came in 2016 and 2020: Net Margin tumbled 143709 bps in 2016, then tumbled 27245196 bps in 2020.
- Over 3 years, Net Margin stood at 1595.48% in 2016, then slumped by 149 bps to 3973.04% in 2019, then sank by 6858 bps to 276425.0% in 2020.
- According to Business Quant data, Net Margin over the past three periods registered 276425.0%, 228725.0%, and 3973.04% for Q4 2020, Q3 2020, and Q4 2019 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 12.74% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -3.12% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -16.51% |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1,361.10% |
| Dec 31, 2020 | -276,425.00% |
| Sep 10, 2020 | -228,725.00% |
| Dec 31, 2019 | -3,973.04% |
| Dec 31, 2016 | -1,595.48% |
| Dec 31, 2015 | -158.39% |